Free Trial

Graham Capital Management L.P. Makes New $280,000 Investment in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Graham Capital Management L.P. acquired a new stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 961 shares of the company's stock, valued at approximately $280,000.

A number of other hedge funds have also bought and sold shares of the business. Waldron Private Wealth LLC grew its position in shares of Molina Healthcare by 4.7% in the fourth quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock valued at $212,000 after purchasing an additional 33 shares in the last quarter. Angeles Investment Advisors LLC boosted its stake in Molina Healthcare by 5.4% in the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after purchasing an additional 43 shares during the period. Coldstream Capital Management Inc. grew its holdings in Molina Healthcare by 2.1% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock valued at $683,000 after buying an additional 48 shares in the last quarter. Lindbrook Capital LLC grew its holdings in Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock valued at $60,000 after buying an additional 57 shares in the last quarter. Finally, Quadrant Capital Group LLC boosted its holdings in Molina Healthcare by 11.4% in the 4th quarter. Quadrant Capital Group LLC now owns 627 shares of the company's stock valued at $182,000 after purchasing an additional 64 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. The trade was a 5.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 89,169 shares of company stock worth $28,520,995. 1.26% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on MOH shares. Sanford C. Bernstein initiated coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective for the company. Baird R W cut shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Truist Financial boosted their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Robert W. Baird reiterated a "neutral" rating and issued a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Finally, Mizuho increased their target price on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $365.38.

View Our Latest Report on Molina Healthcare

Molina Healthcare Trading Down 1.9%

NYSE MOH traded down $6.08 on Wednesday, hitting $320.07. The company's stock had a trading volume of 383,832 shares, compared to its average volume of 687,182. The firm has a market cap of $17.35 billion, a P/E ratio of 15.67, a PEG ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23. The company's 50-day simple moving average is $324.59 and its 200 day simple moving average is $308.35. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the company earned $5.73 earnings per share. The firm's revenue for the quarter was up 12.2% on a year-over-year basis. Research analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines